148 related articles for article (PubMed ID: 2934516)
21. Region-specific serotonin1A receptor turnover following irreversible blockade with EEDQ.
Keck BJ; Lakoski JM
Neuroreport; 1996 Nov; 7(15-17):2717-21. PubMed ID: 8981454
[TBL] [Abstract][Full Text] [Related]
22. Dopamine receptor reappearance after irreversible receptor blockade: effect of chronic estradiol treatment of ovariectomized rats.
Lévesque D; Di Paolo T
Mol Pharmacol; 1991 May; 39(5):659-65. PubMed ID: 1674586
[TBL] [Abstract][Full Text] [Related]
23. Guanyl nucleotide and divalent cation regulation of cortical S2 serotonin receptors.
Battaglia G; Shannon M; Titeler M
J Neurochem; 1984 Nov; 43(5):1213-9. PubMed ID: 6491656
[TBL] [Abstract][Full Text] [Related]
24. Irreversible blockade of high-affinity choline uptake in rat brain by N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline (EEDQ).
Vickroy TW; Malphurs WL
Biochem Pharmacol; 1994 Sep; 48(6):1281-7. PubMed ID: 7945422
[TBL] [Abstract][Full Text] [Related]
25. Recovery of alpha 2-adrenoceptor binding and function after irreversible inactivation by N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline (EEDQ).
Adler CH; Meller E; Goldstein M
Eur J Pharmacol; 1985 Oct; 116(1-2):175-8. PubMed ID: 2865161
[TBL] [Abstract][Full Text] [Related]
26. Effect of chronic estradiol treatment on brain dopamine receptor reappearance after irreversible blockade: an autoradiographic study.
Morissette M; Lévesque D; Di Paolo T
Mol Pharmacol; 1992 Sep; 42(3):480-8. PubMed ID: 1357544
[TBL] [Abstract][Full Text] [Related]
27. Pituitary and brain D2 receptor density measured in vitro and in vivo in EEDQ treated male rats.
Ekman A; Eriksson E
Life Sci; 1991; 48(4):321-31. PubMed ID: 1824955
[TBL] [Abstract][Full Text] [Related]
28. In vivo estimates of efficacy at 5-HT1A receptors: effects of EEDQ on the ability of agonists to produce lower-lip retraction in rats.
Koek W; Assié MB; Zernig G; France CP
Psychopharmacology (Berl); 2000 May; 149(4):377-87. PubMed ID: 10867965
[TBL] [Abstract][Full Text] [Related]
29. Rate of recovery of D1 and D2 dopaminergic receptors in young vs. adult rat striatal tissue following alkylation with ethoxycarbonyl-ethoxy-dihydroquinoline (EEDQ).
Kula NS; George T; Baldessarini RJ
Brain Res Dev Brain Res; 1992 Apr; 66(2):286-9. PubMed ID: 1535031
[TBL] [Abstract][Full Text] [Related]
30. Regional variability in changes in 5-HT2A receptor mRNA levels in rat brain following irreversible inactivation with EEDQ.
Raghupathi RK; Artymyshyn R; McGonigle P
Brain Res Mol Brain Res; 1996 Jul; 39(1-2):198-206. PubMed ID: 8804728
[TBL] [Abstract][Full Text] [Related]
31. Analysis of [3H]spiperone binding sites in the rat striatum and frontoparietal cortex by means of quantitative receptor autoradiography after inactivation of dopamine receptors by N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline in vivo: selective protection by sulpiride in the striatum.
Fuxe K; Meller E; Goldstein M; Benfenati F; Agnati LF
Neurosci Lett; 1986 Feb; 64(2):163-8. PubMed ID: 3960398
[TBL] [Abstract][Full Text] [Related]
32. Inactivation of 5-HT1A and [3H]5-HT binding sites by N-ethoxycarbonyl-2-ethoxy-1, 2-dihydroquinoline (EEDQ) in rat brain.
Subhash MN; Srinivas BN; Vinod KY; Jagadeesh S
Neurochem Res; 1998 Oct; 23(10):1321-6. PubMed ID: 9804289
[TBL] [Abstract][Full Text] [Related]
33. Inactivation of D1 and D2 dopamine receptors by N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline in vivo: selective protection by neuroleptics.
Meller E; Bohmaker K; Goldstein M; Friedhoff AJ
J Pharmacol Exp Ther; 1985 Jun; 233(3):656-62. PubMed ID: 2861276
[TBL] [Abstract][Full Text] [Related]
34. A comparison of the selectivities of SCH 23390 with BW737C89 for D1, D2 and 5-HT2 binding sites both in vitro and in vivo.
Riddall DR
Eur J Pharmacol; 1992 Jan; 210(3):279-84. PubMed ID: 1351844
[TBL] [Abstract][Full Text] [Related]
35. Age-dependent differences in the rate of recovery of striatal dopamine D1 and D2 receptors after inactivation with EEDQ.
Crawford CA; Rowlett JK; McDougall SA; Bardo MT
Eur J Pharmacol; 1994 Feb; 252(2):225-31. PubMed ID: 8157063
[TBL] [Abstract][Full Text] [Related]
36. Functional recovery of D1 dopamine receptor-mediated stimulation of rat striatal adenylate cyclase activity following irreversible receptor modification by N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline (EEDQ): evidence for spare receptors.
Battaglia G; Norman AB; Hess EJ; Creese I
Neurosci Lett; 1986 Sep; 69(3):290-5. PubMed ID: 2945128
[TBL] [Abstract][Full Text] [Related]
37. In vivo partial inactivation of dopamine D1 receptors induces hypersensitivity of cortical dopamine-sensitive adenylate cyclase: permissive role of alpha 1-adrenergic receptors.
Trovero F; Hervé D; Blanc G; Glowinski J; Tassin JP
J Neurochem; 1992 Jul; 59(1):331-7. PubMed ID: 1351927
[TBL] [Abstract][Full Text] [Related]
38. N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline, an irreversible receptor inactivator, as a tool for measurement of alpha 2-adrenoceptor occupancy in vivo.
Pilc A; Nowak G; Zak J
Eur J Pharmacol; 1992 Feb; 212(1):109-11. PubMed ID: 1348228
[TBL] [Abstract][Full Text] [Related]
39. In vivo binding of [3H]ketanserin on serotonin S2-receptors in rat brain.
Laduron PM; Janssen PF; Leysen JE
Eur J Pharmacol; 1982 Jun; 81(1):43-8. PubMed ID: 7117369
[TBL] [Abstract][Full Text] [Related]
40. Anatomical localization of SKF-38393-induced behaviors in rats using the irreversible monoamine receptor antagonist EEDQ.
Neisewander JL; Ong A; McGonigle P
Synapse; 1995 Feb; 19(2):134-43. PubMed ID: 7725242
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
